Drug Database
Back to search

Japan· JP-4490038F1020

セベトラルスタット

A sebetralstat product containing セベトラルスタット, registered in Japan by ＫａｌＶｉｓｔａ　Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ　Ｊａｐａｎ, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

On Japan’s NHI price listATC B06AC08

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedセベトラルスタットATCB06AC08REGISTER NO.JP-4490038F1020PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about セベトラルスタットAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sebetralstat is registered in 9 of 19 countries.

Countries holding a registration under ATC B06AC08 (sebetralstat), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 6 of them publish a price we can compare per daily dose
Search sebetralstat products by name

Sebetralstat · ATC B06AC08

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
セベトラルスタット
Manufacturer
ＫａｌＶｉｓｔａ　Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ　Ｊａｐａｎ
Country
Japan (JP)
ATC code
B06AC08
ATC class
Sebetralstat
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under B06AC08

Sebetralstat, as other registers publish it.

All sebetralstat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/edbf1368-250f-4863-bc1e-0e822b2d88a6
GET /v1/drugs/edbf1368-250f-4863-bc1e-0e822b2d88a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "３００ｍｇ１錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4490038F1020",
  "category": "内用薬",
  "price_yen": 13200,
  "generic_name": "セベトラルスタット",
  "product_name_jp": null,
  "therapeutic_class": "4490",
  "transitional_expiry": "13200"
}
API referenceMCP serverPlans

See everything about sebetralstat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console